Globus Medical Inc. Reports Quarterly Results for Period Ended June 30, 2026

What Happened

• Globus Medical, Inc. announced on August 6, 2026 that it issued a press release reporting its sales and operating results for the three- and six-month periods ended June 30, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K and is incorporated by reference in the filing. The report was signed by Kyle R. Kline, Chief Financial Officer.

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02 and Item 9.01).
• Reporting periods: three-month and six-month periods ended June 30, 2026.
• Exhibit included: Press Release (Exhibit 99.1) containing the sales and operating results.
• Form signed by: Kyle R. Kline, Chief Financial Officer and Senior Vice President.

Why It Matters

• The 8-K signals that the company has released its latest quarterly operating and sales results; investors should read the attached press release for specific revenue, profit, and guidance figures. Because the Form 8-K itself furnishes the press release rather than restating metrics, the press release (Exhibit 99.1) is the primary source for evaluating recent earnings and revenue performance.